Blackstone Life Sciences

Colm Foley is a Managing Director at Blackstone Life Sciences, where he leads Medical Technology sector investing across devices, diagnostics, and life science tools, and has worked on deals spanning pharmaceuticals, medical technology, diagnostics, and CDMOs. He previously spent 23 years at Boston Consulting Group, including nine years as a Senior Partner, leading its global Medical Technology Sector from 2011 to 2014 and its North American Healthcare Practice from 2014 to 2018. Earlier in his career he worked as a technical architect, and he holds degrees from the University of Michigan and the University of Chicago.

Aitian Li is an investor at Calculus Capital, focusing on B2B SaaS, life science, TMT, and manufacturing sectors across UK and Asian markets. With seven years as a generalist investor and three years specializing in financial due diligence for private equity deals, Li is a qualified CICPA and has worked on transactions from Series A through post-Series C via direct and Fund of Funds investments. Completed deals include Tencent Music Entertainment, Grab, Mobike, WeDoctor, Notify, Optalitix, Tagomics, Riff Raff Entertainment, and Wonderhood Studio.

Dominic Harris is Head of Portfolio Management at Calculus Capital, where he oversees the origination, structuring, execution and portfolio management of investments in mid-market businesses. His work includes developing and implementing business plans and collaborating with portfolio company management teams on decision-making and change initiatives. He has over fifteen years of investment banking experience in financial analysis, investment appraisal, valuation and modelling, and holds a Master's in Finance and the ACA qualification.

Susan McDonald is Chairman and Co-Founder of Calculus Capital, focusing on investing in smaller companies and the UK's Enterprise Investment Scheme (EIS). In 1999/2000 she structured and launched the UK's first HMRC-approved EIS fund alongside John Glencross, and she has directed investment into over 80 companies across a range of sectors. Before Calculus, she was Director and Head of Asian Equity Sales at Banco Santander and previously worked at Jardine Fleming, Robert Fleming and Peregrine Securities; she holds an MBA from the University of Arizona and a BSc from the University of Florida.

Jim Breyer made one of venture capital's defining investments when he led Accel's 2005 Series A in Facebook. He founded Breyer Capital in 2006 and later relocated the firm to Austin, where he invests across AI, healthcare, and fintech.

Advisory board member; CTO of Blackstone and former Group CTO at Barclays.

Fintech executive, investor and entrepreneur. President of Payments International and former Chairman of Earthport plc prior to its sale to Visa. Former sole US board member of the IMF, with roles at GE Capital and First Data/Western Union.

Strategic advisor with background including LeSportsac, Blackstone, and Serena and Lily.